Dr. Griffin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
495 Cooper Road Suite 400
Fl 3
Westerville, OH 43081Phone+1 614-627-1420Fax+1 864-225-2592
Education & Training
University of South Florida MorsaniResidency, Obstetrics and Gynecology, 2000 - 2003- University of South Florida MorsaniFellowship, Gynecologic Oncology, 2003
ECU Health Medical Center/East Carolina UniversityInternship, Obstetrics and Gynecology, 1996 - 2000
Vanderbilt University School of MedicineClass of 1996
Certifications & Licensure
OH State Medical License 2024 - 2026
FL State Medical License 2000 - 2025
SC State Medical License 2005 - 2025
GA State Medical License 2022 - 2024
NC State Medical License 1996 - 2019- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Member South Atlantic association obstetrics and gynecology, 2010
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
- Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsAdenocarcinoma in situ of the cervix in pregnancy.David Griffin, Tracy A. Manuck, Mitchel S. Hoffman
Gynecologic Oncology. 2005-05-01 - 29 citationsA phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endom...Kathleen N. Moore, Michael W. Sill, Meaghan Tenney, Christopher J. Darus, David Griffin
Gynecologic Oncology. 2015-09-01 - 26 citationsMolecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cellsDavid Griffin, Sylvie Wittmann, Fei Guo, Ramadevi Nimmanapalli, Purva Bali
Gynecologic Oncology. 2003-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
